Labiotech: The Rollercoaster of Repurposing an Arthritis Drug for Covid-19
May 10, 2021
Read the article with CEO Tara Heitner and COO Malin Berthold telling the story how Cyxone initiated the Covid-19 trial.
Read the article here.